Top Keywords: 2019, sitc, asco, final analysis of, final analysis, gm csf, s plus, csf, gm, analysis of, final, analysis, trials, influencers, population, conferences, s, all rights reserved, rights reserved, all rights, plus, copyright, rights, trastuzumab, beta, terms of service, of service, key, terms of, in high risk, multicenter phase, figures for, 2019 final, prospective randomized, a prospective, high risk, Theres a total of 65 keywords.

Statistics

We first found this page on 2023-03-19 00:00:14 +0000. It was last re-indexed on 2024-12-27 06:39:11 +0000 and with a fetch interval of 90 days it will be fetched again in 82 days on 2025-03-26 or soon thereafter.

Last fetch returned code 200, OK, the current page state is ACTIVE.

Traffic Data for clin.larvol.com

If you are the owner of /clin.larvol.com and you want to remove this page from the search results, just use robots.txt

Similar Sites

letetresgene autoleucel (GSK3377794) / Adaptimmune

News for letetresgene autoleucel (GSK3377794) / Adaptimmune
https://delta.larvol.com/Products/?ProductId=820f7bec-269a-4386-84a9-9a882752b452 - Details - Similar

demcizumab (OMP-21M18) / Mereo Biopharma, BMS

News for demcizumab (OMP-21M18) / Mereo Biopharma, BMS
https://delta.larvol.com/Products/?ProductId=b49bfa5d-4278-4a59-920c-895f72de9a49&Index=0 - Details - Similar

TAC101-Claudin18.2 / Triumvira

News for TAC101-Claudin18.2 / Triumvira
https://delta.larvol.com/Products/?ProductId=6c67a8c2-e9ec-40b8-82fc-3db2d5bcbe47&Index=0 - Details - Similar

pogalizumab (MOXR0916) / Roche

News for pogalizumab (MOXR0916) / Roche
https://delta.larvol.com/Products/?ProductId=7591eddc-448c-4182-b56c-3a445f36dc22 - Details - Similar

More sites similar to ASCO-SITC 2019: Final analysis of Nelipepimut-S plus GM-CSF with trast...

Find Another Website

Search - Add URL

Sponsored Results

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less

Your Ad Here & Hundreds of Other ISEDN Engines & Directories- $3/Month or Less